The tweet was deleted by the author.
But we saved everything 🙂.
REGENXBIO has acknowledged the critical contributions of its administrative team, commending their expertise and execution in keeping company operations running smoothly.
In a statement, the company expressed gratitude for the ongoing commitment and hard work of its staff, emphasizing the meaningful impact they have on its overall success. Details are being clarified.
REGENXBIO has previously participated in community events supporting the development of Duchenne treatments. The company has also expanded its AFFINITY DUCHENNE study with a focus on patient and family support. These initiatives reflect ongoing efforts alongside its internal operations.